News Digest / Income Statements / Standex Reports Strong Sales Growth but Faces Challenges with Organic Decline and Rising Costs

Standex Reports Strong Sales Growth but Faces Challenges with Organic Decline and Rising Costs

StockInvest.us
02:03pm, Friday, May 02, 2025
Illustration by StockInvest.us

Standex International Corporation (NYSE: SXI) has released its latest quarterly report for the period ending March 31, 2025. Here’s a concise overview of key developments from the company's income statement and financial performance:

Positive Aspects:

  • Net Sales Growth: Net sales increased by $30.5 million (17.2%) YoY to $207.8 million, largely due to recent acquisitions contributing $46.7 million.
  • Gross Margin Improvement: The gross profit margin improved to 39.7%, up from 38.5% in the same quarter last year, benefitting from acquisition contributions and productivity initiatives.
  • Profitability Metrics: Income from continuing operations rose to $22.8 million ($1.83 per share) compared to $15.9 million ($1.35 per share) during Q3 2024.
  • Accumulated Other Comprehensive Income: A reversal in the accumulated loss resulted in a total comprehensive income of $32.8 million for the quarter.
  • Cash Flow Management: The company reported an effective interest coverage ratio of 9.42:1 and a leverage ratio of 2.78:1, indicating strong liquidity management.
  • Growing Backlog: The total backlog grew to $270.3 million, reflective of increased customer demand driven by recent acquisitions.

Negative Aspects:

  • Organic Sales Decline: Organic sales decreased by 8.1% YoY due to weak demand in the automotive segment and general industrial end markets.
  • Rising Interest Expenses: Interest expenses surged to $8.4 million in Q3 2025, compared to just $0.9 million in Q3 2024, prompted by the increased debt load from acquisitions.
  • Restructuring Costs: Restructuring expenses amounted to $1.98 million in Q3 2025, reflecting ongoing cost-cutting measures but indicating operational challenges.
  • Acquisition-Related Costs: The company recorded $2.15 million in acquisition-related expenses during the quarter, elevating overall operational costs.
  • Net Income Decrease: Net income attributable to Standex decreased to $21.88 million from $40.93 million in the previous year’s nine-month period, impacted by increased costs and lower sales in some segments.

Key Statistics:

  • Net Sales: $207.78 million (Q3 2025) vs. $177.27 million (Q3 2024)
  • Gross Profit: $82.43 million (39.7% margin) vs. $68.29 million (38.5% margin)
  • Income from Operations: $26.25 million (Q3 2025) vs. $21.84 million (Q3 2024)
  • Interest Expenses: $8.36 million (Q3 2025) vs. $0.95 million (Q3 2024)
  • Net Income: $21.88 million attributed to shareholders
  • Effective Tax Rate: (29.6%) for Q3 2025 vs. 21.4% for Q3 2024

This snapshot reflects a company managing growth through acquisitions while facing challenges in organic growth and rising costs. The market's response to the overall financial health and strategic decisions will be vital for future performance.

About The Author

StockInvest.us

StockInvest.us is a stock market research tool that provides daily stock signals and technical analysis for over 25 000 tickers on 38 exchanges. The company was founded in 2016 in Vilnius, Lithuania.

Trusted Broker
Start Your Journey With:
eToro
0% Commission Stock Trading
Follow Other Investors Strategy
Wide variety: Crypto, stocks, ETFs

Securities trading offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk.